These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. The mediating effects of depression, anxiety, and rapid eye movement sleep behavior disorder on the association between dopaminergic replacement therapy and impulse control disorders in Parkinson's disease. Du S; Huang Y; Ma Y; Qin Y; Cui J; Bai W; Han H; Zhang R; Yu H Neurol Sci; 2023 Feb; 44(2):557-564. PubMed ID: 36221041 [TBL] [Abstract][Full Text] [Related]
44. Differential contributions of depression, apathy, and anxiety to neuropsychological performance in Parkinson's disease versus essential tremor. Ratajska AM; Scott BM; Lopez FV; Kenney LE; Foote KD; Okun MS; Price C; Bowers D J Clin Exp Neuropsychol; 2022 Nov; 44(9):651-664. PubMed ID: 36600515 [TBL] [Abstract][Full Text] [Related]
45. Gender differences in motor and non-motor symptoms among Sardinian patients with Parkinson's disease. Solla P; Cannas A; Ibba FC; Loi F; Corona M; Orofino G; Marrosu MG; Marrosu F J Neurol Sci; 2012 Dec; 323(1-2):33-9. PubMed ID: 22935408 [TBL] [Abstract][Full Text] [Related]
46. Impulse control and related behaviors in Parkinson's disease with dementia. Martinez-Martin P; Wan YM; Ray Chaudhuri K; Schrag AE; Weintraub D Eur J Neurol; 2020 Jun; 27(6):944-950. PubMed ID: 32048392 [TBL] [Abstract][Full Text] [Related]
47. Nonmotor Symptoms and Impulse Control Disorders in Parkinson's Disease Patients in India: A Cross-sectional Study. Varshney A; Kumar P; Ram VS Ann Afr Med; 2024 Jul; 23(3):400-405. PubMed ID: 39034565 [TBL] [Abstract][Full Text] [Related]
48. Interaction Between Neuropsychiatric Symptoms and Cognitive Performance in Parkinson's Disease: What Do Clinical and Neuroimaging Studies Tell Us? Hanganu A; Monchi O Curr Neurol Neurosci Rep; 2018 Oct; 18(12):91. PubMed ID: 30324260 [TBL] [Abstract][Full Text] [Related]
49. Psychosis, apathy, depression and anxiety in Parkinson's disease. Gallagher DA; Schrag A Neurobiol Dis; 2012 Jun; 46(3):581-9. PubMed ID: 22245219 [TBL] [Abstract][Full Text] [Related]
50. Reverters from PD-MCI to cognitively intact are at risk for future cognitive impairment: Analysis of the PPMI cohort. Jones JD; Kuhn TP; Szymkowicz SM Parkinsonism Relat Disord; 2018 Feb; 47():3-7. PubMed ID: 29233608 [TBL] [Abstract][Full Text] [Related]
51. Psychiatric Manifestation in Patients with Parkinson's Disease. Han JW; Ahn YD; Kim WS; Shin CM; Jeong SJ; Song YS; Bae YJ; Kim JM J Korean Med Sci; 2018 Nov; 33(47):e300. PubMed ID: 30450025 [TBL] [Abstract][Full Text] [Related]
52. Imaging behavioural complications of Parkinson's disease. Valli M; Mihaescu A; Strafella AP Brain Imaging Behav; 2019 Apr; 13(2):323-332. PubMed ID: 28856542 [TBL] [Abstract][Full Text] [Related]
53. Subjective Cognitive Complaints in Parkinson's Disease: A Systematic Review and Meta-Analysis. Siciliano M; Tessitore A; Morgante F; Goldman JG; Ricciardi L Mov Disord; 2024 Jan; 39(1):17-28. PubMed ID: 38173220 [TBL] [Abstract][Full Text] [Related]
54. The independent influence of apathy and depression on cognitive functioning in Parkinson's disease. Butterfield LC; Cimino CR; Oelke LE; Hauser RA; Sanchez-Ramos J Neuropsychology; 2010 Nov; 24(6):721-30. PubMed ID: 20853956 [TBL] [Abstract][Full Text] [Related]
55. Apathy and impulse control disorders in Parkinson's disease: a direct comparison. Leroi I; Andrews M; McDonald K; Harbishettar V; Elliott R; Byrne EJ; Burns A Parkinsonism Relat Disord; 2012 Feb; 18(2):198-203. PubMed ID: 22035735 [TBL] [Abstract][Full Text] [Related]